NCT00544921View on ClinicalTrials.gov

Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Diabetes

Interventions

DRUG

GLY-230

OTHER

Placebo

No drug administered

Trial Locations (1)

Unknown

Univ FL, Gainesville

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

University of Florida

OTHER

lead

Glycadia

INDUSTRY